Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

933
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
933
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

893
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
893
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

322
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

475
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
475
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

376
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
376
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

369
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
369

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Environmental risk factors and cardiovascular health.

European heart journal·2026
Same author

Impact of Ambient Air Pollution on Cardiovascular Diseases in Low- and Lower-Middle-Income Countries: A Systematic Review and Meta-Analysis.

Global heart·2026
Same author

Breathing Fire: Cumulative Wildfire Smoke Exposure as a Cardiovascular Risk Factor.

Journal of the American College of Cardiology·2026
Same author

A systematic review of observational studies on long-term air pollution exposure and epigenetic alterations in adults.

Journal of global health·2026
Same author

Community Knowledge, Attitudes and Preventive Behaviour Towards the Cardiovascular Benefits of Reduced Exposure to Air Pollution in Nigeria: Evidence from the CARDINAL Study.

Global heart·2025
Same author

A comprehensive review/expert statement on environmental risk factors of cardiovascular disease.

Cardiovascular research·2025

相关实验视频

Updated: Jan 18, 2026

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model
07:35

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model

Published on: December 10, 2021

2.4K

空气污染和动脉样硬化

Anusha N Seneviratne1, Mark R Miller2

  • 1Department of Health Studies, Royal Holloway University of London, Egham, UK.

Atherosclerosis
|May 24, 2025
PubMed
概括

空气污染通过促进动脉样硬化 - - 心脏病发作和中风的关键因素 - - 显著促进心血管疾病. 减少空气污染物暴露提供了大量的心血管健康益处.

科学领域:

  • 环境健康 环境健康
  • 心血管医学 心血管医学
  • 毒理学 毒理学 毒理学

背景情况:

  • 空气污染是一个主要的全球健康问题,与显著的心血管死亡率和发病率有关.
  • 动脉样硬化是一种以斑块积累为特征的血管疾病,是许多心血管事件的基础,如中风和心肌梗塞.
  • 对空气污染的暴露,无论是急性还是慢性,都会加剧动脉样硬化的各种方面.

研究的目的:

  • 审查流行病学证据,将空气污染暴露与动脉样硬化的形态测量联系起来.
  • 总结空气污染在不同疾病阶段促进动脉样硬化的生物机制.
  • 为证据提供视角,并建议未来的研究方向.

主要方法:

  • 对相关空气污染暴露与动脉样硬化标志物的流行病学研究的审查 (例如,状动脉内脏介质厚度,冠状动脉和大动脉结石化).
  • 综合有关生物通路的当前知识,解释空气污染在动脉样硬化发展中的作用.
  • 对现有的证据基础进行批判性评估.

主要成果:

  • 流行病学数据显示,空气污染暴露与动脉样硬化负担增加之间存在关联.
  • 生物机制包括炎症,氧化应激和内皮功能障碍,导致斑块形成和破裂.
  • 证据强烈支持空气污染和动脉样硬化进展之间的因果关系.
关键词:
空气污染 大气污染动脉样硬化 动脉样硬化心血管疾病的心血管疾病颗粒物质颗粒物质是什么

更多相关视频

Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
10:11

Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies

Published on: October 22, 2014

19.6K
Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters
05:18

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters

Published on: July 12, 2024

696

相关实验视频

Last Updated: Jan 18, 2026

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model
07:35

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model

Published on: December 10, 2021

2.4K
Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
10:11

Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies

Published on: October 22, 2014

19.6K
Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters
05:18

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters

Published on: July 12, 2024

696

结论:

  • 空气污染是动脉样硬化和随后的心血管事件的重要环境风险因素.
  • 尽量减少对空气污染物的暴露,为公共卫生提供了减少心血管病理的关键机会.
  • 迫切需要采取行动,以减轻空气污染对心血管健康的影响.